![]()
To view a list of our studies: click here
ICON - Manchester's Clinical Research Organisation
ICON Development Solutions is one of the
Organisations, and we run many different studies. We are located close to The University of Manchester and the Manchester Royal Infirmary. Formed in 1983, we evolved from the
Today we are part of Icon Clinical Research, a Global company with 37 operations in 23 countries across the World. ICON’s Manchester Unit currently has an 80-bed capacity and a staff of 180, making us one of the largest dedicated Phase 1 clinical research organisations in 
We have been conducting clinical trials for over 20 years and our reputation for safety, scientific integrity and compliance allows us to enjoy a first class reputation with clients from major pharmaceutical companies and volunteers who participate in our trials.
The safety of all volunteers is our primary concern at ICON. All studies are conducted under internationally agreed guidelines set down by the US Food and Drug Administration (FDA) and the UK Medicine and Healthcare Products Regulatory Agency (MHRA). Each study is reviewed by an Independent Ethics Committee who is responsible for ensuring that your safety
has been thoroughly considered, that the information provided to you is fair, balanced and accurate and that your rights as a volunteer are maintained.
We really do value volunteers time and commitment. We rely on volunteers to help with our studies. In return for helping us, our volunteers may receive up to £3,000 or more, depending on the type and length of the study. It's a great way to meet people, relax and enjoy our entertainment facilities - not the daunting experience you may have expected! 
Our volunteers are compensated financially, but most also join a study because they’re keen to help the world of medicine progress new treatments which may improve the quality of life of people all over the World. Your contribution is that important.
To apply to our clinic or for more information please contact:
0800 328 8000







